National study finds life-threatening barriers in access to breakthrough drugs

Most states violate federal Medicaid law because they deny coverage for sofosbuvir, a new and highly effective treatment to cure hepatitis C. According to a team of researchers who examined Medicaid policies for hepatitis C virus treatment using sofosbuvir, more commonly known as Solvadi, most should change policy to improve access to the treatment.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1U4wdlH